Pharma Journalist -

The U.S. Food and Drug Administration (FDA) has approved Lantheus Holdings’ TAUKLARIFY (florquinitau F 18 injection), a radiodiagnostic agent designed to help identify tau pathology in…
Read More...

Aurisco Pharmaceutical has announced that its manufacturing site in Yangzhou, China, has successfully passed a U.S. Food and Drug Administration (FDA) inspection. The company said the…
Read More...

Alfasigma S.p.A. has agreed to acquire Nordic Pharma, a specialty pharmaceutical company with operations across Europe, Canada and Japan, in a move that will expand Alfasigma’s…
Read More...

Eli Lilly and Company has filed six new lawsuits against U.S. entities accused of selling unauthorized retatrutide products, escalating the pharmaceutical company's efforts to combat…
Read More...

Summit Therapeutics has announced that its partner Akeso has received marketing authorization from China’s National Medical Products Administration (NMPA) for ivonescimab in combination…
Read More...

Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has entered into an option and license agreement with clinical-stage rare…
Read More...

Infinimmune, a biotechnology company developing fully human antibody therapeutics derived directly from the human immune system, has raised $75 million in a Series A financing round to…
Read More...

Remepy, a biotechnology company developing a new class of medicines that combine prescription drugs with personalized, AI-driven therapeutic applications, has raised $36 million in a…
Read More...

Epicrispr Biotechnologies, a clinical-stage biotechnology company developing programmable epigenetic medicines, has raised $90 million in an oversubscribed Series C financing round to…
Read More...

Industry leaders from Gilead Sciences, Sanofi, Eli Lilly, Takeda, Bristol Myers Squibb, Novartis and more will gather to address safety, translational predictability, biomarker strategy…
Read More...